Food Science and Technology Department

 

Department of Food Science and Technology: Faculty Publications

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents

Katherine M. Weh, Medical College of Wisconsin
Jennifer L. Clarke, University of Nebraska-Lincoln
Laura A. Kresty, Medical College of Wisconsin

Document Type Article

Weh, Clarke, & Kresty in MDPI Antioxidants (2016) 5. Copyright © 2016, the authors. Licensee MDPI, Basel, Switzerland. Open access, Creative Commons Attribution license 4.0.

Abstract

Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.